Chelating agents for the binding of metal ions to antibodies.

Chelating agents for the binding of metal ions to antibodies. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Chelating agents for the binding of metal ions to antibodies. Abstract Text:

C F Meares,

The development and applications of bifunctional chelating agents are reviewed, with emphasis on the preparation of radiolabeled monoclonal antibodies suitable for use in vivo. Major principles and practical aspects of the chemical procedures are outlined, and new results of interest for future work are described.

Chelating agents for the binding of metal ions to antibodies. Publishing Authors By Initials

CF Meares,

For similar biochemical phenomena, metabolism, and nutrition: biochemical phenomena: protein binding research abstracts see: biochemical phenomena, metabolism, and nutrition: biochemical phenomena: protein binding research

PUBMED ID PMID:

MEDLINE DATE:

Chelating agents for the binding of metal ions to antibodies. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: International journal of radiation applications an

VOLUME: 13

Page Numbers: 311-8

Journal Abbreviation:

ISSN: 0883-2897

DAY: 21

MONTH: 02

YEAR: 1986

Chelating agents for the binding of metal ions to antibodies. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8611098

Chelating agents for the binding of metal ions to antibodies. Keywords Mesh Terms:

KEYWORDS: Protein Binding

MESH TERMS:

Chemical & Substance for Abstract: Chelating agents for the binding of metal ions to antibodies. Information

Substance Name: Pentetic Acid

Registry Number: 67-43-6

Grant and Affiliation Information for Chelating agents for the binding of metal ions to antibodies.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Rad Appl Instrum B

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Chelating agents for the binding of metal ions to antibodies Related Publications

• "Missing links" in borderline personality disorder: loss of neural synchrony relates to lack of emotion regulation and impulse control.
• A rare earth-DOTA-binding antibody: probe properties and binding affinity across the lanthanide series.
• Antibodies with infinite affinity: origins and applications.
• Anxiety reactions in hypnosis.
• Chelating agents for the binding of metal ions to antibodies.
• Cysteinylated protein as reactive disulfide: an alternative route to affinity labeling.
• Editorial: What's New.
• Event related response variability in schizophrenia: effect of intratrial target subsets.
• Extended-field radiation therapy for carcinoma of the prostate: a progress report.
• Giant cyst of the seminal vesicle with renal agenesis.
• Infectious urethritis in men and women. Diagnosis and treatment.
• Maximum variance of late component event related potentials (190-240 ms) in unmedicated schizophrenic patients.
• Measurement of maximum variability within event related potentials in schizophrenia.
• Measuring perceived spatial quality changes in surround sound reproduction.
• Numbers of preceding nontargets differentially affect responses to targets in normal volunteers and patients with schizophrenia: a study of event-related potentials.
• Regional differentiation of cortical activity in schizophrenia: a complementary approach to conventional analysis of regional cerebral blood flow.
• Single trial variability within the P300 (250-500 ms) processing window in adolescents with attention deficit hyperactivity disorder.
• Smooth pursuit eye tracking dysfunction and negative symptoms in schizophrenia.
• Strategies for enhancement of radioimmunotherapy.
• The chemistry of irreversible capture.
• The effects of age on auditory event-related potentials.
• What makes the patient better?
• What makes the patient better? Atavistic regression as a basic factor.